Diversity in immunogenomics: the value and the challenge
- PMID: 34002093
- PMCID: PMC8842483
- DOI: 10.1038/s41592-021-01169-5
Diversity in immunogenomics: the value and the challenge
Abstract
Immunogenomics studies have been largely limited to individuals of European ancestry, restricting the ability to identify variation in human adaptive immune responses across populations. Inclusion of a greater diversity of individuals in immunogenomics studies will substantially enhance our understanding of human immunology.
Conflict of interest statement
Competing interests
V.G. declares advisory board positions in aiNET GmbH and Enpicom B.V. P.K. is a co-founder of Inflammatix, Inc. He is also a consultant to Inflammatix, Inc., Vir Biotechnology, Cepheid, and Genentech. G.K.H and M.C. are founders of ImmuneDiscover Sweden AB.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources